Zhengye Biotechnology Holding (ZYBT) Shares Outstanding (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Shares Outstanding (Entity) for 3 consecutive years, with $6.7 million the latest figure, recorded in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 5.1% year-over-year to $6.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.7 million (up 5.1% YoY) and the FY2025 annual result came in at $6.7 million, up 5.1% from the prior year.
• Shares Outstanding (Entity) advanced to $6.7 million in Q4 2025 per ZYBT's latest filing, from $6.6 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for ZYBT reached as high as $6.7 million in Q4 2025 and fell as low as $6.3 million in Q4 2023.
• A 3-year average of $6.5 million and a median of $6.5 million in 2025 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) climbed 0.24% — and 2025, when it advanced 5.1%.
• Year by year, Shares Outstanding (Entity) stood at $6.3 million in 2023, then advanced by 0.24% to $6.4 million in 2024, then advanced by 5.1% to $6.7 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $6.7 million, $6.6 million, and $6.4 million for Q4 2025, Q2 2025, and Q4 2024 respectively.